Insights › Market reaction

Why Immuron (IMRN) Stock Rose 3.00% in 10 Minutes on Oct 13, 2026

81,078 shares changed hands in those 10 minutes.

Published in ET: Feed time in ET: Company news IMRN +3.00% in 10 min after the headline
  • IMRN rose 3.00% in the 10 minutes after the 06:02:13 ET headline, from $1.00 to $1.03.
  • The headline crossed in pre-market trading, 3 hours 28 minutes before the 9:30 ET open.
  • The first minute pointed the other way: -1.99% at one minute, +3.00% at 10 minutes.
IMRN Why Immuron (IMRN) Stock Rose 3.00% in 10 Minutes on Oct 13, 2026
MoveSurge publish 06:02:13 ET
MoveSurge publish
06:02:13 ET
1.19 1.11 1.04 0.96 1.03 06:00 06:02 06:12
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
IMRN 1.00 1.00 0.98 1.03 -1.99% +3.00%

Immuron (IMRN) shares rose 3.00% in the 10 minutes after this headline reached the MoveSurge news feed at 06:02:13 ET on Tuesday, October 13, 2026: “Immuron announced the publication of Phase 2 results for Travelan in Scientific Reports, noting the trial missed primary efficacy targets due to a low placebo illness rate.”

IMRN in the first 10 minutes

From a reference price of $1.00 just before the headline, the stock was down 1.99% after one minute and up 3.00%, at $1.03, after 10 minutes. The first minute pointed the other way before the stock turned. 81,078 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 3 hours 28 minutes before the 9:30 ET open.

Immuron at a glance

SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
Market value$9 million (as of Oct 12, 2026)

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Immuron stock on October 13, 2026?

At 06:02:13 ET, this headline crossed: “Immuron announced the publication of Phase 2 results for Travelan in Scientific Reports, noting the trial missed primary efficacy targets due to a low placebo illness rate.” The stock rose 3.00% in the next 10 minutes.

How far did IMRN move after the headline?

From $1.00 just before the headline to $1.03 10 minutes later, a +3.00% move.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes recorded price reactions, search, watchlists, alerts and research tools.

Create free accountGo real time Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.